Titlebook: Cannabinoids and Neuropsychiatric Disorders; Eric Murillo-Rodriguez,S. R. Pandi-Perumal,Jaime M Book 2021 The Editor(s) (if applicable) an

最后一個(gè)

Cannabis and Depression, may lead to the onset of depression; however, strong evidence points to the inverse association; i.e. that depression may lead to the onset or increase in cannabis use frequency. Observational and epidemiological studies have not indicated a positive long-term effect of cannabis use on the course a

聾子

打谷工具

Cannabidiol Therapy for Refractory Epilepsy and Seizure Disorders,s for treatment of drug-resistant epilepsy. In 2018, the FDA approved the use of CBD-rich Epidiolex for two severe forms of epilepsy in children (Lennox-Gastaut and Dravet syndromes). Experimental research supports the use of CBD in many CNS disorders, though the mechanisms underlying its anticonvul

Blasphemy

Cannabinoid-Based Medicines and Multiple Sclerosis,ed by recent studies. MS is a chronic, immune-mediated, and demyelinating disorder of the central nervous system with no cure so far. It is widely reported that cannabinoids might be used to control MS symptoms and that they also might exert neuroprotective effects and slow down disease progression.

indifferent

表皮

10樓

摘要

10樓